Mesothelin-Targeted Immunotoxin LMB-100 in People With Malignant Mesothelioma

NCT02798536 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

NIH

Sponsor class

Conditions

Mesothelioma

Interventions

DRUG: LMB-100
DRUG: nab-paclitaxel

Sponsor

National Cancer Institute (NCI)